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V. Mechanisms of Cellular Adaptation in Long-Term DL-A
Identical Radiation Chimeras*
BY F. T. RAPAPORT,t H. S. LAWRENCE, R. BACHVAROFF, F. D. CANNON,
D. BLUMENSTOCK, N. MOLLEN, J. H. AYVAZIAN, AND J. W. FERREBEE
(From the Departments of Surgery andMedicine, New York University Medical Center, New York,
10016; The Mary Imogene Bassett Hospital (Affiliated with Columbia University), Cooperstown,
New York 13326; and The Manhattan Veterans' Administration Hospital,
New York 10010)
Significant advances have been made in the definition of the serologically
detectable (SD)' and lymphocyte surface-reactive (LD) products of the main
histocompatibility complex in a variety of mammalian species, including the dog
(1-18) and man (19-33). Such progress has not, however, produced dramatic
improvements in the results of bone marrow transplantation. Reports from
Thomas' group (34-36) have indicated that attempts to reconstitute suprale-
thally irradiated dogs with DL-A identical bone marrow frequently result in
lethal graft-vs.-host (GVH) disease in the recipients. Clinical application ofbone
marrow transplantation has been hampered similarly by GVH reactions of
unpredictable severity and/or mortality in patients treated with marrow ob-
tained from an HL-A SD and LD identical sibling donor (37-40).
Different results have been achieved, however, in the colony of selectively bred
beagles maintained at The Mary Imogene Bassett Hospital in Cooperstown,
N. Y. Transplantation of bone marrow from prospective genotypically DL-A
identical Cooperstown donors into supralethally irradiated littermate and
nonlittermate recipients has regularly resulted in the establishment of a
long-term state of chimerism, with no evidence of GVH disease in the recipients
(41-46). Such chimeras have also been rendered specifically tolerant to skin (43),
kidney (41), heart (A. D. Boyd, personal communication), lung (47), liver (49),
and pancreatic (49) allografts obtained from the bone marrow donor. Evidence
has been presented, however, that donor-recipient pairs selected on the basis of
* Supported by grant AI-10658-03, National Institutes of Health, Bethesda, Md. ; in part by The
John A. Hartford Foundation, Inc. ; National Institutes of Health grants AM-02215 and
AM-14059-15, and U. S. Atomic Energy Commission contract AT(11-1)-3327.
$ Irma T. Hirschl Career Scientist Award.
'Abbreviations used in this paper: GVH, graft-vs.-host, LD, lymphocyte surface reactive; SD,
serologically detectable.
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DL-A identity are genetically heterogeneous for non-DL-A histocompatibility
determinants (4, 6, 16, 43, 50-53) and a number of other markers (43-45).
The availability of a population of stable long-term chimeras and of their
respective bone marrow donors has provided an opportunity to investigate the
mechanism(s) whereby bone marrow cells transplanted into a host bearing
non-DL-A incompatibilities become engrafted and proliferate. The long-term
adaptation of such allogeneic cells to their new incompatible milieu is also of
relevance to the question of whether somatic mutations mayhave occurred in the
transplanted cells (44). The studies presented in this report support the
conclusion that the inhibition ofresponses of transplanted bone marrowcells and
their progeny to the non-DL-A alloantigens present in the irradiated host is a
consequence of a central state of cellular unresponsiveness, and is not due to
humoral factors. Reversal of tolerance has been achieved by irradiation of the
original marrow donor, followed by return to this donor of marrow obtained from
its corresponding chimera. Upon recovery, the reconstituted dogs had the
capacity to reject skin allografts obtained from their chimeral partner. Repeated
exposure to skin obtained from the original chimera has resulted in accelerated
skin graft rejection responses in the reconstituted dogs. It has also conferred on
the immunologically competent cells of such dogs the capacity to induce lethal
secondary disease in their respective chimeras. The evidence also indicates that
bone marrow cells and their progeny can retain their germ-line characteristicsfor
as long as 4.5 yr after transplantation into a (non-DL-A) histoincompatible
environment.
Materials and Methods
Selection of Donors and Recipients.
￿
14 of a series of 20 adult male and female bone marrow
transplant donor-recipient pairsof beagles of the Cooperstown Colony (Tables I, II)weighing 17-271bs
were used. Each pair of dogs hadbeen selected forbone marrow transplantation on thebasisof geno-
typic evidence ofDL-A identity (20, 43), confirmedby lymphocytotoxicity testsperformedwith DL-A
antisera capable of detecting 12 SD specificities, as described previously (43). Identity for LD
products of the DL-A complex was tested in standard fashion by the mixed leukocyte culture
technique(12) . Erythrocyte groupantigens A, C, and D were determined by thetechniques of Swisher
andYoung (55) . In referring to each pair of dogs presented in this study, theoriginal donorof marrow
will be termed "A" and the original recipient chimera, "B".
Method of Irradiation andBone Marrow Transplantation.
￿
The method of supralethal total body
irradiation from two opposing" Co sources, yielding 1,2000-1,400 R used in this study has been
described in detail previously (43). Bone marrow transplantation wasperformed by the intravenous
infusion into the recipient of a suspension of 3.0-3.5 x 10°nucleated bone marrow cells obtained by
needle aspiration of the long bones and sternum of the donor (43). This was given within 12 to 18 h
afterirradiation. Leukocyte and platelet levels were determined in the recipients three times weekly
for the first21 days and at weekly intervals thereafter. Thereturn of leukocyte and platelet levels to
normal values after transplantation and absence of detectable GVH disease provided evidence of
successful take and proliferation of the bone marrow transplant (43). Persistence of chimerism was
periodically confirmed in informative pairs by testing for the continuing presence of donor
erythrocyte antigens on the recipient's erythrocytes and of sex characteristics of donor cells in the
recipient's peripheral leukocytes (43, 56).
Method of Skin Grafting and Criteria for the Diagnosis of Allograft Rejection.
￿
The method of
skin grafting has been described earlier (43). Briefly, it consists of the transplantation of
full-thickness skin specimens measuring 2 x 2 cm, using the intact panniculus carnosus of the
recipient as the graft bed. The grafts were examined dailyafter the 7th postoperative day; standard122
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criteria (43) were used forthe diagnosisof allograftrejection; thelatter was confirmed by subsequent
sloughing of the eschar. All grafts were performed in duplicate.
Basic Experimental Sequence
ATTEMPT TO PROLONG SKIN ALLOGRAFT SURVIVAL WITH CHIMERAL SERUM.
￿
Beginning within 6-8 m af-
terthe establishment ofchimerism, 10-mlserumsamples were drawn weekly from eight "B"dogs and
from an untreated DL-A identicallittermate of an "A"dog. The sera from each dogwere pooled and
stored at -70°C before use. Each of the eight corresponding "A" dogs was given skin grafts from its
"B" partner, andreceived, 5, 10, or 20 ml of serum from its chimera intravenously on thedayof skin
transplantation and daily thereafter, until rejection of the grafts. One dog received 5 ml of normal
serum, following a similar schedule, andwas grafted in the same manner. The resultswere compared
with thoseobtained with grafts placed on untreateddogs under thesame conditions of DL-A identity
(Table III).
IRRADIATION AND RECONSITUTION OF THE ORIGINAL DONORS OF MARROW WITH BONE MARROW OBTAINED
FROM THEIR CORRESPONDING CHIMERAS .
￿
Within 14-21 days after rejection of the "B" skin grafts, the
nine sensitized "A" dogs and 5 additional "A" dogs were irradiated and reconstituted with a
transplant of marrow obtained from their "B" partner (Table IV). After recovery, all 14 "A" dogs
were given skin grafts from-the corresponding "B" animal (Table V) . The first nine "A" dogs were
grafted within 36-295 days after reconstitution with "B" marrow (Table V). Each of these dogs had
rejected "B" skin grafts before being subjected to irradiation and transplantation with "B" marrow.
The otherfive "A" animals, whichhadnotbeen sensitized earlier, received theirfirst "B" skin grafts
within 171-206 days after reconstitution with "B" marrow (Table V).
TEST OF THE ABILITY OF THE RECONSTITUTED ORIGINAL DONORS OF MARROW TO REJECT SUCCESSIVE SKIN
GRAFTS FROM THEIR CHIMERAS . "B" skin grafts were given in consecutive fashion to the corresponding
"A" partner, within 2-3 wk after rejection of each preceding graft, until each "A" dog received four
sets of"B" grafts. One "A" dog (no. 21-74) didnotreject its first-set "B"graft; this animal received a
second-set graft at 122 days after the first graft, a third-set at 68 days after the second, and a
fourth-set at 37 days after the third-set graft (Tables V and VI).
REIRRADIATION OF THE ORIGINAL CHIMERAS AND PRETREATMENT WITH MARROW AND BLOOD CELLS FROM
THE ORIGINAL DONOR SENSITIZED BY FOUR SUCCESSIVE SETS OF CHIMERA SKIN GRAFTS .
￿
The final series of
experiments were aimed at an assessment of the ability of bone marrow and/or blood leukocytes
obtained from "A" dogs sensitized with four sets of "B" skin grafts to produce GVH disease in their
corresponding "B" partner. For this purpose, each of the "B" dogs was irradiated and received bone
marrow from its "A" partner; this was given within 2-8 days after that particular "A" dog had re-
jected its fourth-set "B" graft. Five "B" dogs were treated with 1.2-2.0 x 109 nucleated "A" bone
marrow cells and2-12 transfusions of 125-ml aliquots ofwhole "A"bloodwhichhadbeen irradiated by
exposure to 1,000 R for 18-20 min, using a standard `°CO source. Another three "B" dogs were given
2.1-3.0 x 109 "A" marrow cells and three to six transfusions of unirradiated "A" blood (Table VII) .
Five "B" dogs received 1.01-2.8 x 109 "A" bone marrow cells and 1.29 to 8.36 x 109 "A" leukocytes
suspended in donor plasma, given intravenously at the time of marrow transplantation, and at 5- to
8-day intervals thereafter (Table VIII). These dogs were also treated with two to six transfusions of
125-ml aliquots of irradiated wholebloodobtained from a normal DL-A identical donor. The doses of
bone marrow cells and the degree of contamination of such cells with peripheral blood leukocytes were
roughly comparable in the groups of dogs treated with irradiated whole blood, unirradiated blood, or
blood leukocytes.
Results
Background Data .
￿
Table I presents the long-term follow-up of the series of
bone marrow chimeras maintained at the Cooperstown Colony for thepurposes of
this study. It consists of 11 littermate and 9 nonlittermate pairs of supralethally
irradiated and reconstituted animals ("B") and their donors ("A"), with a
survival of 882-1,466 days in the 20 consecutive recipients of marrow ("B").
Persistence of chimerism was confirmed by determination of the presence of3 0
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donor Swisher erythrocyte antigens andleukocyte sex characteristics in the blood
of the recipient. Table II illustrates the survival of each chimera, with normal
renal function, at 833-1,402 days after bilateral nephrectomy and transplanta-
tion of a kidney from the donor of marrow. Skin grafts from the same donor
continued to survive at 928-1,020 days (one graft was rejected at 84 days). The
"A" skin or kidney grafts to "B" dogs were not affected by any of the subsequent
procedures.
TABLE II
Responses to Donor-Specific Kidney and Skin Allografts in DL-A Identical Bone Marrow
Chimeras*
* 31 July 1973.
t DL-A-incompatible skin grafts were rejected by the same animals within 10.5-26 days (43).
Effect of Chimeral Serum Upon Skin Allograft Survival .
￿
As noted in Table
III, "A" dogs treated with serum obtained from their long-term bone marrow
chimera partners ("B") rejected "B" skin grafts at 26, 39, 13, 75, 27, 19, 22, and
26 days, respectively. There was no obvious relationship between the duration of
graft survival and the total volume of serum administered. One "A" dog given
normal serum rejected its "B" graft at 24 days. The survival time accorded to
skin allografts in normal, untreated DL-A identical Cooperstown dogs was 22-29
days (43) .
Donor Recipient Relation
Survival
Renal allograft from
donor of marrow
time of:
Skin allograft from
donor ofmarrow$
days days
21-59 21-60 Littermates > 1,402 84
21-62 21-61 >1,401 >999
21-65 21-66 > 1,378 >983
21-74 21-73 > 1,303 -
22-21 22-22 > 1,275 -
21-95 21-96 >1,262 >943
22-32 22-29 > 1,199 >1,020
22-03 22-04 > 1,198 -
22-43 22-40 > 1,134 >937
22-55 22-48 > 1,055 >932
22-95 22-94 > 885 -
21-87 21-56 Nonlittermates >1,226 >964
21-90 21-97 > 1,182 >964
22-06 22-24 > 1,170 >949
22-51 22-57 > 1,042 >931
22-52 22-56 > 1,021 >931
22-46 22-07 >1,012 >931
22-13 22-73 >918 >928
23-09 21-94 >833 -
23-03 23-08 >839 -RAPAPORT ET AL .
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TABLE III
Reactiuity to Skin Allografts Obtained from Long-Term Bone Marrow Chimeras in the
Corresponding Donors of Marrow Treated with Chimeral Serum
* Survival ofskin allografts in untreated DL-Aidentical beagles, 22-29days (mean survival time, 25.5 days) (43).
$Recipient given normal serum from a DL-A identical littermate donor.
Irradiation and Reconstitution ofNormal and Preimmunized Original Donors
of Marrow ("A") with Bone Marrow from the Corresponding Chimeras ("B").
Table IV compares the results of reconstitution ofirradiated "A" dogs with bone
marrow from their corresponding "B" chimera, with and without prior sensitiza-
tion of "A" with "B" skin allografts. When "A" dogs sensitized with "B" skin
were irradiated and given "B" marrow, uniformly successful engraftment oc-
curred, and the "A" dogs are surviving with no evidence of secondary disease for
727, 755, 756, 713, 538, 759, 719, and 712 days, respectively. "A" dogs not grafted
with "B" skin before marrow transplantation from "B" are surviving in similar
fashion for 750, 715, 708, 663, and 633 days, respectively
Response of Reconstituted "A" Dogs to Successive "B" Skin Grafts . As
summarized in Table V, first-set "B" skin allografts were rejected by unir-
radiated "A" dogs within 13-39 days; one graft survived for 75days. First-set "B"
skin grafts placed on the five unsensitized "A" dogs at 196, 171, 171, 159, and 206
days, respectively, after irradiation and reconstitution with "B" marrow cells
(dogs 21-74, 22-55, 22-95, 22-52, and 23-03) were rejected at 88, 24, 62, and 34
days, respectively; one graft (dog 21-74) continues to survive at 654 days (Table
V). Challenge of the first nine "A" dogs (dogs 21-62, 21-66, 21-95, 22-43, 22-32,
22-06, 22-51, 21-90, and 22-46) with second-set skin grafts from the correspond-
ing "B" partner within 168, 133, 105, 274, 45, 36, 295, 34, and 59 days,
respectively, after irradiation and reconstitution with "B" marrow, resulted in
skin graft survivals of 16, 14, 23, 22, 21, 12, 20, 24, and 14 days, respectively
(range, 12-24 days). Subsequent "B" skin grafts placed upon the corresponding
"A" dog after rejection of the immediately preceding transplant were accorded
progressively decreasing survival times, as is illustrated in Table VI. One
exception was "A" dog 21-74, which remained unresponsive to all skin grafts
from its "B" partner. The latter transplants are surviving for 654, 532, 465, and
428 days, respectively.
Reirradiation of "B" Dogs andReconstitution with Cellsfrom the "A" Partner
Bone
marrow
donor
Recip-
ient
Relation-
ship
Daily
dose of
chimera
serum
Treatment
ofdonor
ofmarrow
Total
volume
ofserum
given
Survival of skin
grafts from chimera
placed on the donor
of marrow (days)
ml days ml days
21-62 21-61 LM 5 24 120 24$
22-51 22-57 Non-LM 5 26 130 26
21-66 21-65 LM to 38 380 39
22-06 22-24 Non-LM 10 13 130 13
21-95 21-96 LM 10 75 750 75
22-43 22-40 LM 10 27 270 27
22-32 22-29 LM 10 19 190 19
21-90 21-97 Non-LM 20 22 440 22
22-46 22-07 Non-LM 20 26 520 26126 CELLULAR ADAPTATION IN DL-A IDENTICAL RADIATION CHIMERAS
TABLE IV
Results of Irradiation and Reconstitution of Normal and of Preimmunized Original
Donors of Marrow (Dogs A) with Bone Marrow Obtained from Their Corresponding
Long-Term DL-A Identical Chimeras (Dogs B)
*All reconstituted A dogs are surviving uneventfully, with no evidence of secondary disease, as of 1
December 1974.
$+, immunized against dog B tissues by skin grafting (all grafts rejected; mean survival time, 34.8
days).
§ -, No pretreatment with B tissues.
Sensitized by "B" Skin Grafts.
￿
Within 2-8 days afterrejection of the fourth-set
skin graft, (the interval was 20 days after fourth-set grafting in dog 21-74, which
failed to reject "B" skin grafts), the "B" dogs were irradiated and received
marrow from their corresponding "A" partner, in which evidence of hypersensiti-
zation to "B" skin grafts had been obtained in all butone instance. As illustrated
in Table VII, four of five "B" dogs reconstituted with "A" marrow and given
transfusions of irradiated "A" blood survive uneventfully for 336, 484, and 482
days, respectively ; one animal succumbed of secondary disease within 76 days
after marrow transplantation. In contrast, three consecutive "B" dogs treated
with "A" marrow, but given unirradiated blood transfusions from the sensitized
"A" donor, had an initial engraftment of the transplanted marrow, but died of
severe secondary disease within 28, 44, and 49 days.
A third group of five "B" dogs was irradiated and reconstituted with "A"
marrow and received intravenous injections of peripheral blood leukocytes
isolated from the same sensitized "A" donor of marrow. As outlined in Table
VIII, two of the recipients (dogs 21-73 and 22-48) showed no evidence of
engraftment and succumbed at 12 and 15 days, respectively; two other animals
DogA DogB
Donor-
recipient
relationship
Duration of
chimerism in
B before
present
experiment
Immunological
status ofdogA
before present
experiment
Resultsofsurvival
of repopulation of
dogAwith bone
marrow obtained
from its
chimera(B)*
days days
21-62 21-61 LM )1,446 +$ )727
21-65 21-66 LM >1,426 + >755
21-95 21-96 LM )1,352 + >756
22-43 22-40 LM >1,185 + >713
22-32 22-29 LM )1,261 + )538
22-06 22-24 Non-LM >1,239 + >538
22-51 22-57 Non-LM >1,101 + >759
21-90 21-97 Non-LM )1,300 + >719
22-46 22-07 Non-LM )1,032 + >712
21-74 21-73 LM >1,405 - >750
22-55 22-48 LM >1,136 - >715
22-95 22-94 LM >965 - >708
22-52 22-56 Non-LM )1,400 - )663
23-03 23-08 Non-LM >882 - >663TABLE V
Response ofIrradiated and ReconstitutedA Dogs to Successive Skin Allografts Obtained
from their Corresponding B Partners
* As of 1 December 1974.
*MST, mean survival time.
Survival ofB skin
grafts before andafter
irradiation and
RAPAPORT ET AL .
Survival of successive Bskin grafts applied
to Adogs at 2-3 wk intervals after
rejection of the preceding graft
Discussion
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TABLE VI
Sensitization of A Dogs to Specific Non-DL-A Antigens Through the Transplantation of
Successive Skin Allografts from the Same B Partners
had an early graft take, followed by severe secondary disease and death at 16 and
28 days, respectively; one dog is surviving at 343 days . The "B" recipient (no.
21-73) of marrow and leukocytes from "A" dog 21-74, which had not rejected its
"B" grafts, succumbed after failure of engraftment.
Progress in organ transplantation continues to await the perfection of currently
available techniques to produce allograft tolerance without interference with the
DogA Dog B
reconstitution
with marrow
from B
from the same donor (listed
graft numbers postirradiation
reconstitution of Adogs)
as
and
Before After Graft no. 2 Graft no. 3 Graft no. 4
days days days days days
21-62 21-61 24 16 14 13 -
21-66 21-65 39 14 10.5 12 -
21-95 21-96 75 23 25 12 -
22-43 22-40 27 22 19 16 -
22-32 22-29 19 21 13 13 -
22-06 22-24 13 12 11 11 .5 -
22-51 22-57 26 20 18 17 -
21-90 21-97 22 24 13 10 -
22-46 22-07 26 14 13 14 -
21-74 21-73 - >654* >532 >465 >428
22-55 22-48 - 88 20 19 14
22-95 22-94 - 24 12.5 13 10
22-52 22-56 - 62 100 33 23
23-03 23-08 - 34 31 23 17
Type of
graft
No. ofA
dogs 0-10 10-15
No. ofdogs
16-20
rejecting
21-25
skin
26-30
allografts
31-35
on postoperative
36-40
day:
41-60 61-80 81-90 >90
MST*
days
1st-setgrafts 14 1 1 3 3 1 1 2 1 1 36.8
2nd-set grafts 4 3 4 1 2 25.3
3rd-set grafts 7 3 2 1 1 17.2
4th-set grafts 2 7 3 1 1 14.0128
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TABLE VII
Reconstitution of Irradiated B Dogs with Bone Marrow from their Original A Partner, After
Sensitization with B Skin Allografts; Effect of Blood Transfusion from the Donor of Marrow
* 1 December 1974.
remainder of the host's defense mechanisms . The feasibility of this approach was
originally demonstrated by the induction of immunological tolerance by Billing-
ham et al. (57) . The distinctions between the latter type of classical immunologi-
cal tolerance (i.e., central) and a variety of other modalities, including immuno-
logical enhancement (58-60) and the facilitation of allograft survival by pretreat-
ment of adult recipients with histocompatibility antigens(s) (61-63), have become
increasingly tenuous in recent years (64).
In further studies of this question in thecanine species, Ferrebee and associates
in Cooperstown, New York (65-68), produced chimerism in randomly selected
dogs after supralethal total body irradiation and bone marrow transplantation,
and demonstrated that the recipients which occasionally survived treatment
tolerated allografts obtained from the donor of marrow (67). Methods were not
available at that time, however, for the prospective selection of donors and
recipients, so as to permit the creation of long-term bone marrow chimeras in
predictable fashion. Recent advances in the genetic definition of the main
histocompatibility complex in the dog (DL-A) have provided an opportunity to
achieve this goal through the establishment of selectively bred lines of beagles of
known DL-A genotype in the Cooperstown Colony (6, 7, 16, 44-46) . Extension of
the approach of Thomas and Ferrebee (67) to genotypically DL-A identical
littermate and nonlittermate Cooperstown Colony dogs has resulted in the
regular long-term survival of irradiated bone marrow chimeras, with evidence of
persisting chimerism (56) and no detectable GVH disease (43). Evidence of the
genetic heterogeneity of these pairs of donors ("A" dogs) and recipients ("B"
dogs) has been secured by detection of markers other than the products of the
DL-A complex, particularly for non-DL-A alloantigens (43, 46). Nevertheless,
these chimeras have shown specific tolerance to allografts of other organs
obtained from the donor of marrow (references 43 and 47-49; and A. D. Boyd,
personal communication).
Time between Blood transfusions from donor ofmarrow:
rejection oflast Dose of Treatment Timingof Survival
Dog A Dog B Bgraft by A and A
of Total transfusions ofB
transplantation of marrow transfused volumeof after marrow No. recipient*
A marrow into B blood transfusions transplantation
days ml days days
21-62 21-61 2 2.0 x 101 Irradiated 250 12,23 2 >482
21-65 21-66 8 1 .6 x 10' " 875 9,11,16,21,25,32,38 7 >484
22-06 22-24 8 1.2 x 10' " 375 10,14,16 3 >484
22-51 22-57 6 1 .8 x 10' " 625 9,14,19,23,26 5 >336
21-95 21-96 8 1.5 x 10' 1,500 12,15,19,23,28,35, 12 76
44,54,56,58,61,75
22-32 22-29 8 2.1 x 10' Unirradiated 500 11,13,18,25 44
22-46 22-07 6 2.5 x 101 " 750 10,13,15,20,24,31 49
21-90 21-97 8 3.0 x 10' 375 4,10,21 283
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In contrast to the survival rates attained in the Cooperstown Colony, DL-A
identical bone marrow transplants performed in other canine populations
(34-36), as well as HL-A identical marrow transplants in man (37-40) have been
associated with a significantly high incidence of lethal GVH disease. A possible
explanation for the success of the long-term chimeras in Cooperstown dogs and in
a certain proportion of the dogs tested in other canine populations (34-36) is that
such donor-recipient combinations may share sufficient non-DL-A alloantigens
to avoid triggering GVH disease after transplantation of marrow (43, 44).
Although such a sharing appears to be a consequence of selective breeding in the
restricted genetic pool of the Cooperstown Colony (44), it has been a chance
occurrence in the other reported series (34-36). In spite of the sharing of some
non-DL-A alloantigens, untreated genotypically DL-A identical Cooperstown
dogs do, however, differ by sufficient concentrations of such antigens to cause
rejection of first-set allografts of all organs tested in this colony, including skin,
kidney, heart, lung, and liver (4, 6, 16, 43, 50-53) .
The precise nature of the mechanism(s) of allogeneic unresponsiveness
operative in radiation chimeras has remained uncertain. The detection of
blocking antibodies of the Hellstr6m et al . type (69) in long-term canine bone
marrow chimeras similar to those of the Cooperstown Colony has prompted the
suggestion that this type of humoral factor(s) might be responsible for the
establishment and maintenance of chimeral tolerance (70) . The results of the
present study do not support this conclusion . Treatment of "A" dogs with serum
obtained from long-term "B" chimeras reconstituted by "A" marrow has failed
to significantly prolong the survival of "B" skin grafts placed on the "A" partner.
In addition, the continuous exposure of marrow, whole blood, or leukocyte
suspensions of sensitized "A" dogs to chimeric serum had no effect upon the
ability of such cells to produce severe secondary disease in irradiated "B"
recipients . Tsoi et al. (71) have also independently and simultaneously (46)
observed that serum from bone marrow chimeras has no effect upon the survival
of chimeral skin allografts placed on the donor of marrow, even if occasional
serum samples had a blocking effect in vitro, and Brent et al . (72) have reported
similar negative in vivo results in mice rendered tolerant during the neonatal
state.
Epstein et al. (56) have provided evidence pointing to the repopulation of
radiation chimeras by donor bone marrow cells and their progeny. There are no
other definitive data, however, on the possible regeneration of some of the
long-term chimeric dogs' own clones of immunologically competent cells. It is
also not clear whether somatic mutations can occur in the transplanted cells or
their progeny, as a consequence of their continuous exposure to an incompatible
(non-DL-A alloantigens) milieu (54) . In the course of this study, untreated "A"
dogs and "A" dogs which had rejected skin allografts from their corresponding
"B" chimera were irradiated and given bone marrow from "B". All grafts were
successful, with no evidence of GVH disease. There was no difference in the
outcome of marrow transplantation in "A" dogs sensitized to first-set "B" skin
grafts, and in those which had not received "B" grafts. Storb et al. (73) have
shown that allogeneic sensitization of a prospective recipient by blood transfu-RAPAPORT ET AL .
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sion before irradiation acts as a barrier to the success of bone marrow transplan-
tation from the same donor. The results of this study therefore indicate that the
contribution of the irradiated "B" host's cells to repopulation of its bone marrow
and derived cells was nil or insufficient to be detectable by this test system. The
engraftment and proliferation of marrow from "B" in "A" also militate against
the possibility that the originally transplanted "A" stem cells and their progeny
developed somatic mutations against "self" during their prolonged sojourn in the
"B" host. Rather, the results are compatible with the conclusion that such cells
preserve their original germ-line properties (54), without changes in information
storage in the foreign in vivo milieu.
After reconstitution with marrow cells obtained from their "B" chimera, all
but 1 of 14 "A" dogs had the capacity to reject skin allografts from "B". Previous
contact with "B" skin caused differences in the type of response accorded to "B"
grafts. Challenge of "A" dogs with a second-set "B" skin graft after irradiation
and reconstitution with "B" marrow resulted in an accelerated rejection
response, which occurred when the grafts were transplanted within 34-59 days
after reconstitution of the "A" dogs, as well as when a longer waiting period of
143-295 days was allotted, in order to ensure recovery of immunological function
by the host (74) . In contrast, four of five "A" dogs given first-set "B" grafts at
159-206 days after irradiation and reconstitution with "B" marrow rejected the
skin grafts at 24, 34, 62, and 88 days, respectively; one animal remains
unresponsive to "B" grafts.
The ability of "A" dogs reconstituted with "B" marrow to reject skin grafts
from "B" suggests that the "A" marrow stem cells originally transplanted into
the "B" dogs (and their progeny) have retained the capacity to recognize and to
react against the non-DL-A histoincompatibilities present in "B" host tissues.
The ability to muster an allograft response (such as a GVH reaction) was
inhibited, however, while "A" cells remained in the "B" environment. Upon the
return of such cells to their original "A" milieu, the "A" dogs gradually regained
the ability to reject "B" tissues. Taken together, the evidence suggests that the
allogeneic unresponsiveness resulting from exposure of "A" cells to the "B"
milieu may be mediated by a mechanism akin to classical immunological
tolerance, with inhibition of the clonal proliferation required to produce
antigen-reactive lymphocytes (55, 75, 76), and without clonal elimination due to
terminal differentiation.
It is of interest that second-set "B" skin grafts placed on reconstituted "A"
dogs which had rejected a first-set of "B" graft before irradiation were accorded a
decrease in survival time. The similar results obtained early and late after
irradiation suggest that this response may be a consequence of the persistence in
the irradiated host of radioresistant immunologically competent primed cells.
Such a possibility is consonant with the observation that preirradiation blood
transfusions can interfere with the success of bone marrow transplantation (73,
77), and highlights the potential importance of host-vs.-graft reactions as
determinants of the success of bone marrow transplantation.
Once the reconstituted "A" dogs rejected a "B" skin graft, subsequent grafts
from the same donor were accorded progressively decreasing survival times, a132
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possible indication of increasing rates of lymphocyte proliferation in response to
repeated antigenic stimulation. The interval between each successive graft was
deliberately kept at 2-3 wks, in order to induce accelerated rejection, rather than
white graft responses (78), in preparation for a cellular transfer of allograft
sensitivity from the hypersensitized "A" dogs to their "B" partner. Previous
reports indicate that leukocytes obtained from individuals sensitized by repeated
skin grafts from the same donor have the capacity to transfer specific allograft
sensitivity to third-party recipients (78). In the present study, the intravenous
injection of (anti-"B") "A" marrow and irradiated whole blood has successfully
reconstituted four out five supralethally irradiated "B" recipients; secondary
disease, with death at 76 days, occurred in onedog. When unirradiated "A" blood
was used in conjunction with "A" marrow, however, three out of three "B" dogs
died of severe secondary disease within 28-49 days. Only one of five "B" dogs
given "A" marrow and blood leukocytes survived ; two animals had a totalfailure
of engraftment, and succumbed at 12 and 15 days, and the remaining two dogs
died of severe secondary disease at 16 and 28 days, respectively.
These results are consistent with the conclusion that bone marrow and
unirradiated blood, or intact blood leukocytes, from a specifically sensitized
donor can transfer allograft sensitivity to supralethally irradiated canine
recipients, with the production of lethal secondary disease in the target animals.
The ability of "A" cells to transfer allograft sensitivity under the conditions of
this experiment supports the de novo nature of the transferred sensitivity.
Indeed, "A" cells had been shown earlier to lack the capacity to produce
detectable secondary disease in the same "B" recipient, and only acquired this
capacity after the "A" dogs had been hypersensitized with "B" skin grafts. This
observation may be of relevance to the suggestion that cellular transfers of
hypersensitivity might be an expression of the elevation of latent host sensitivity,
rather than conferring a de novo type of reactivity (79, 80).
Cosgrove et al . (81) have reported that bone marrow obtained from parental
donors sensitized with F1 hybrid thymus, liver, or spleen cells can induce severe
early GVH reactions in lethally irradiated F1 hybrid mice. The results of this
study suggest that marrow stem cells may not be as effective as blood leukocytes
in transfers of allograft sensitivity in the canine species. Rather, uch transfers
appear to be mediated primarily by radiosensitive blood leukocyte, a conclusion
that is in harmony with the role of lymphocytes in mechanisms of cellular
hypersensitivity (75, 76). The results also support the conclusion that the GVH
reaction is an expression of cell-mediated immunity amenable to further study
and/or modification by transfer techniques (82, 83).
Summary
20 Cooperstown beagles of known DL-A genotypes ("B" dogs) were exposed to
supralethal total body irradiation and received a bone marrow allograft from a
DL-A identical donor ("A" dog) ; the resulting chimeras have survived unevent-
fully for 882, 1466 days, with no evidence of secondary disease, and have been
tolerant to kidney and skin allografts obtained from the donor of marrow.
Treatment of "A" dogs with serum obtained from their long-term "B"
chimeras had no significant effect upon the ability of the recipients to reject "B"RAPAPORT ET AL.
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skin allografts. Suchgrafts were rejected within 13-39 days; onegraftsurvived for
75 days. Subsequent irradiation and reconstitution ofthe grafteddogs andoffive
additional "A" animals with the marrow obtained from the corresponding "B"
chimeras resulted in the successful engraftment and long-term survival of the
transplanted marrow for 538-759 days. There was no difference between the
results observed in "A" pretreated with a "B" skin graft and in "A" dogs not
given "B" skin grafts.
Rechallenge of skin-grafted "A" dogs with "B" skin transplants after irradia-
tion and reconstitution with "B" marrow resulted in accelerated graft rejections
at 12-24 days ; in contrast, "B" skin grafts placed on five irradiated "A" dogs
given "B" marrow without a previous skin graft survived for 24-88 days; one dog
failed to reject such "B" grafts, which continue to survive at 654 days.
Subsequent "B" skin grafts placed upon the corresponding "A" partners with 2-
3 wk after rejection of the immediately preceding graft were accorded progres-
sively diminished survival times.
When each "B" dog was reirradiated and reconstituted with bone marrowfrom
its "A" partner, which had been sensitized by four consecutive "B" skin grafts,
four of five "B" dogs given "A" marrow and irradiated "A" blood survived
uneventfully. In contrast, three "B" dogs given "A" marrow and unirradiated
"A" blood died ofsecondary disease within 28-49 days, and, fouroffive "B" dogs
given "A" marrow and "A" leukocytes died. There was failure ofengraftment in
two instances and acute secondary disease at 16 and 28 days, respectively, in two
other dogs.
The prospective selection of genotypically DL-A identical pairs of dogs of the
Cooperstown Colony has produced the regularly predictable survival of suprale-
thally irradiated recipients of bone marrow allografts. The resulting chimeras
have survived with no evidence of secondary disease for as long as 4.5 y after
transplantation. The mechanisms of graft-host accomodation operative in this
experimental system may be the consequence of a central inhibition of clonal
proliferation of lymphocytes capable of responding to non-DL-A alloantigens
present in "B" and absent in "A" tissues. Humoral factors do not appear to be
implicated in the mediation of this state of immunological tolerance.
The ability of cells obtained from "A" dogs sensitized by "B" skin grafts to
produce secondary disease in the irradiated "B" hosts appears to be localized
primarily to radiosensitive peripheral blood leukocytes. The results highlight the
potential usefulness of cell transfer techniques as a model for further studies of
the type of cell-mediated allograft sensitivity expressed by the graft-vs.-host
reaction .
The authors acknowledge their appreciation for the excellence of the technical assistance of Mrs.
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Quel at New York University.
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